Centpropazine

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Centpropazine (CPZ, CTZ) is an experimental antidepressant of the phenylpiperazine family which was under development for the treatment of major depressive disorder in India but was never marketed. It is described as having imipramine-like clinical effects, reversing reserpine-induced effects in animals, and potentiating amphetamine-induced effects in animals. The mechanism of action of centpropazine is unknown. The drug reached phase 3 clinical trials prior to the discontinuation of its development. It was first described in the scientific literature by 1980.

Centpropazine (CPZ, CTZ) is an experimental antidepressant of the phenylpiperazine family which was under development for the treatment of major depressive disorder in India but was never marketed. It is described as having imipramine-like clinical effects, reversing reserpine-induced effects in animals, and potentiating amphetamine-induced effects in animals. The mechanism of action of centpropazine is unknown. The drug reached phase 3 clinical trials prior to the discontinuation of its development. It was first described in the scientific literature by 1980.

See also

IHCH-7162 (centpyraquin)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1338042494 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.